Navigation Links
ContinuumRx Forms Healthcare Joint Venture with Mississippi Baptist Health Systems
Date:9/6/2011

JACKSON, Miss. and BIRMINGHAM, Ala., Sept. 6, 2011 /PRNewswire/ -- ContinuumRx and Mississippi Baptist Health Systems (MBHS) of Jackson, Mississippi announced the opening of a new home infusion pharmacy that will serve providers and patients throughout Central Mississippi in a collaborative model designed to improve patient outcomes with a more seamless transition from hospital to home.

"This partnership will not only improve our core operations and patient care, but also benefit the overall health care system at large," said Eric McVey, M.D., Baptist Chief Medical Officer. "We took the time to understand the gaps and problems with how patients and providers access specialized home infusion drugs and quickly saw opportunities for improved care. When we reviewed ContinuumRx in operation with another health system partner, it validated our beliefs in terms of what their model could deliver for Baptist."

Home Infusion services are typically ordered for those patients with high-cost chronic disease states such as cancer, gastrointestinal (GI) problems, heart failure, immunodeficiency disorders, neuromuscular disorders and serious infections. A patient's clinical information moves seamlessly across inpatient and outpatient settings as part of ContinuumRx's integrated services model. Ongoing home therapy progress information is provided to each patient's primary care and specialty physicians electronically or through available consultations, giving physicians access to important clinical information.

"It's invaluable for hospitals to have a specialized outpatient pharmacy as part of their continuum of care," said Brian Booth, ContinuumRx Senior Vice President. "Providers can then be assured that patients with chronic and complex disease states and conditions have their critical medications available before leaving the hospital. Access to and compliance with these high-cost treatments is fundamental to both better patient outcomes and managing the overall cost of treatment. ContinuumRx is committed to better serving patients through close cooperation with hospital systems. We are very pleased to have MBHS as our joint venture partner in the central Mississippi market."

About Mississippi Baptist Health Systems

Mississippi Baptist Health Systems is an integrated healthcare delivery system serving Mississippi with a full complement of tertiary and primary care services. From its beginnings in 1911, its foundation has been built on a Christian healing ministry. In 2011, Baptist ranks nationally in the top five percent in overall Orthopedic Services, Joint Replacement, Vascular Surgery, Prostatectomy, Overall GI Services, and GI Surgery; plus, Baptist has more Five Star Ratings and excellence awards than any hospital in Mississippi, according to HealthGrades, the leading independent healthcare ratings organization. Visit Baptist on the Web at www.mbhs.org.

About ContinuumRx

ContinuumRx is based in Birmingham, Alabama and develops joint ventures with market-leading health systems to provide home infusion and specialty pharmacy services to the patients they serve. Through its unique integrated model with health systems and their affiliated providers, ContinuumRx is creating a better model of care for patients with chronic and complex conditions. Its team of clinical experts and advanced fulfillment model provides hospitals with a seamless service offering that can reduce the patient's length of stay, help avoid unnecessary readmissions and allow payors to reduce overall healthcare costs. For more information, please visit www.continuumrx.com.


'/>"/>
SOURCE ContinuumRx; Mississippi Baptist Health Systems
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. The University of Tennessee Medical Center and ContinuumRx Form Healthcare Joint Venture
2. Allegheny General Hospital Performs First Liver Transplant
3. Medifast Outperforms American Diabetes Association Diet by Twice the Weight Loss According to Published Study
4. UBC Forms European Advisory Board to Enhance Data Quality of CNS Trials
5. Spirit II Results Support Strength of Boston Scientifics Two Drug-Eluting Stent Platforms
6. XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years
7. Exiqon Forms Research Collaboration With M. D. Anderson Cancer Center
8. First Molecular Tem-PCR Test to Identify Multiple Forms of Staph and MRSA Obtains CLIA Certificate
9. InNexus Lead Candidate DXL625 Outperforms Rituxan in Additional Animal Studies
10. Abbotts XIENCE V(TM) Drug Eluting Stent Outperforms TAXUS(R) in Key Efficacy and Safety Endpoints Out to Two Years
11. Raptor Pharmaceuticals Provides Update on Targeting Platforms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... , Oct. 2, 2017 The Rebound mobile app ... struggle to reverse the tide of prescription drug addiction. The ... their medicine intake and stepping down their dosage in a ... launch in December 2017; the first 100,000 people to sign ... at http://www.rebound-solution.com/ ...
(Date:9/25/2017)...   Montrium , an industry leader in ... IQPC Trial Master Files & Inspection Readiness Conference ... Clinical Services has selected eTMF Connect ... EastHORN, a leading European contract research organization (CRO), ... to enable greater collaboration with sponsors, improve compliance ...
(Date:9/19/2017)... venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses pulsed sound ... ... Jim Bertolina, PhD ... Tom Tefft ... device executive Josh Stopek , PhD, who has led R&D and business development teams ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... ... The American College of Medical Informatics (ACMI) will present the 2017 Morris ... of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium is taking ... in the field of medical informatics, this prestigious award is presented to an individual ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about ... intend to develop to enable prevention of a major side effect of chemotherapy ... especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as ...
(Date:10/12/2017)... , ... October 12, 2017 , ... HMP , ... recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ ... on October 11, 2017. , The annual award competition recognizes editorial and design excellence ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the Health & ... by Moonlight to raise money for the American Heart Association Heart Walk. Teams of ... will work together to keep their treadmills moving for 5 hours. Treadmills will start ...
(Date:10/12/2017)... ... 2017 , ... Health Literacy Innovations (HLI), creator of the ... the Cancer Patient Education Network (CPEN), an independent professional organization that shares best ... alliance. , As CPEN’s strategic partner, HLI will help support CPEN members ...
Breaking Medicine News(10 mins):